FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic

Considerations to Support Clinical Trial Monitoring Oversight During COVID-19

Considering developing circumstances, IFAPP is postponing ICPM 2020, March 25-26. We do this with deep disappointment. We’ll develop ICPM within the year  of  2020, and new dates and venue will be announced in our next communication. To read the letter of IFAPP President Kyoko Imamura click here

Following the request of WMA to collect suggestions for the planned revision of the DoH, the IFAPP WG on Ethics recommends to the President of IFAPP and the BoOs to submit on behalf of IFAPP to the WMA the following suggestions by Dr. Gustavo Kesselring. The Members of the WG of Ethics would highly appreciate…

Participants from all over the world will appreciate top level speakers who elaborate on the main message of ICPM, which is the key role of patients in drug development. At www.icpm2020.com you will find the registration page with very competitive and affordable rates, especially for the youngest colleagues amongst us. Attend this biannual IFAPP flagship…

IFAPP, the International Federation of Pharmaceutical Physicians and Pharmaceutical Medicine, invites you to watch the attached videos, summarizing IFAPP recent achievements and future vision of our Federation. To watch the videos click here

Poster presented by the Italian Association of Pharmaceutical Medicine (SIMeF) at the Athens meeting in October 2019

Poster presented by the French Association of Pharmaceutical Medicine (AMMIS) at the Athens meeting in October 2019